Mylan & Merck (5 Generic Drugs) is Buildings and Property in United Kingdom that focus on guanfacine hydrochloride tablets business. They cover business area such as a portfolio, five generic drug, acebutolol hydrochloride capsule, flecainide acetate tablet, guanfacine hydrochloride tablet, nicardipine hydrochloride capsule, hydrochloride af tablet, hypertension and heart problem.
-
Guanfacine Hydrochloride Tablets
-
Building 4, Trident Place
Mosquito Way
Hatfield AL10 9UL
England, United Kingdom
Private
a portfoliofive generic drugacebutolol hydrochloride capsuleflecainide acetate tabletguanfacine hydrochloride tabletnicardipine hydrochloride capsulehydrochloride af tablethypertension and heart problem
* We use standard office opening hours in near Mylan & Merck (5 Generic Drugs)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Mylan & Merck (5 Generic Drugs) is Buildings and Property business from United Kingdom that founded in - ( years old in ), Mylan & Merck (5 Generic Drugs) business is focusing on Guanfacine Hydrochloride Tablets.
Mylan & Merck (5 Generic Drugs) headquarter office and corporate office address is located in Building 4, Trident Place Mosquito Way Hatfield AL10 9UL England, United Kingdom.
Mylan & Merck (5 Generic Drugs) was founded in United Kingdom.
In , Mylan & Merck (5 Generic Drugs) is currently focus on guanfacine hydrochloride tablets sector.
Above is snippet of Google Trends for "guanfacine hydrochloride tablets" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Mylan & Merck (5 Generic Drugs), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
